Skip to main content
Home » What's New » New AREDS Study of Macular Degeneration

New AREDS Study of Macular Degeneration

The AREDS 2 study results are in:

  • The only subgroup which showed a benefit of adding more lutein and zeaxanthin to the current recommended dosage, were those patients who were in the lowest quintile of dietary consumption of lutein and zeaxanthin.
  • The most appropriate recommendation for most patients is incorporate sources of lutein and zeaxanthin into their diet.
  • Omega 3 fatty acids were also shown to have no effect on macular degeneration, when added to the ocular vitamins.



For specific information about AREDS2, visit


Click to learn more about our COVID-19 protocols and procedures